12,5 %The prevalence of overweight/obesity was 12.5% in nursery and primary school children in urban Cameroon.
Camerounoverweight/obesitypublié 2017BMC obesityeurope_pmcdocument de 5 observationsDOI 10.1186/s40608-017-0146-4
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 754 evidences · page 42 / 71
12,5 %The prevalence of overweight/obesity was 12.5% in nursery and primary school children in urban Cameroon.
Camerounoverweight/obesitypublié 2017BMC obesityeurope_pmcdocument de 5 observationsDOI 10.1186/s40608-017-0146-4
Active case search data from June 2026 revealed a high burden of unreported suspected VPDs, primarily measles, concentrated in the East and Southern Africa Block (Mozambique, Malawi, Tanzania, Ethiopia, Kenya, Zambia, and Madagascar), in the DRC-Angola Block (DRC and Angola), in the West Block (Benin, Togo and Guinea), and in the Lake Chad Basin (Nigeria, Chad, Cameroon and Central African Republic).
Angola · Bénin · Cameroun · Éthiopie · Guinée · Kenya · Madagascar · Malawi · Mozambique · Nigeria · RDC · Tanzanie · Tchad · Togo · Zambierougeole · VPDsobservé June 2026WHO Africadocument de 17 observations
74 %74% of patients with type 2 diabetes had poor glycemic control.
Cameroundiabète de type 2publié 2015Diabetes research and clinical practiceeurope_pmcdocument de 5 observations
36,1 %Contrary to Cameroonian doctors who considered termination of an affected pregnancy (TAP) for SCD in 36.1%, the majority of parents (62.5%) with affected children accepted TAP in principle.
Cameroundrépanocytosepublié 2015Public health genomicseurope_pmcdocument de 6 observations
12,1 %The age-standardized prevalence of hypertension was 12.1% in urban women in Cameroon.
Camerounhypertension artériellepublié 1998International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/27.2.181
21,8 %A male chimpanzee (Cam155), 1.5 years old, showed a weight loss of 21.8% from August 2009 to January 2010 (16 to 12.5 kg).
CamerounSIVcpzobservé August 2009 to January 2010publié 2011RetrovirologyOpenAlexdocument de 4 observationsDOI 10.1186/1742-4690-8-4
0,44 proportionThe T allele frequency was significantly higher in the diabetic group (0.44) than in the control group (0.17).
Cameroundiabète de type 2publié 2015Clinical and translational medicineeurope_pmcdocument de 2 observations
43,1 %47 out of 109 patients (43.1%) were predicted to express the RH10 (V) low-frequency antigen.
CameroundrépanocytoseHAL · Unilimdocument de 45 observations
2 %2.0% of the included HIV-infected patients had diabetes.
Cameroundiabète (non précisé)publié 2017Lipids in health and diseaseeurope_pmcdocument de 7 observations
-0,63 mmol/LThe difference in 2-h glucose between those in the highest tertile of plasma Zn compared to the lowest was -0.63 mmol/L.
Cameroundiabète de type 2publié 2023The British journal of nutritioneurope_pmcdocument de 5 observations
Cameroon and Gabon are predicted to have Laverania infection probability dropping between June and August.
Cameroun · GabonLaveraniaHAL · Unilimdocument de 24 observations
11,4 %A significant reduction in HbA1c was observed after 1 year, from 11.4%±2.7% to 8.7±2.4%.
Cameroundiabète de type 1publié 2017BMJ open diabetes research & careeurope_pmcdocument de 7 observations
The prevalence of hypertension in Cameroon increased by twofold to fivefold between 1994 and 2003.
Camerounhypertension artérielleobservé 1994 to 2003publié 2010Journal of epidemiology and community healtheurope_pmcdocument de 3 observationsDOI 10.1136/jech.2008.086355
0 %In Yaoundé, the capital city of Cameroon, the prevalence of WHO-defined transmitted HIV-1 drug resistance mutations (DRMs) among ART-naive individuals was 0.0% in 1996–1999.
CamerounVIH/sidaobservé 1996–1999publié 2011AIDS (London, England)europe_pmcdocument de 5 observationsDOI 10.1097/qad.0b013e32834bbbe9
3,1 %Among 458 patients who initiated antiretroviral therapy in rural district hospitals in Cameroon between 2006 and 2008, 14 (3.1%) classified at WHO clinical stage 4 had a CD4 count above 350 cells/mm³.
CamerounVIH/sidaobservé 2006-2008publié 2010Tropical medicine & international health : TM & IHeurope_pmcdocument de 7 observations
9,2 odds_ratioThere was an association between diabetes and hypertension (OR 9.2 [95% CI: 5.0–16.9]).
Cameroundiabète (non précisé) · hypertension artériellepublié 2017BMC health services researcheurope_pmcdocument de 7 observationsDOI 10.1186/s12913-017-2197-0
58 %58 % des cas de paludisme surviennent dans les 20 % des pays les plus pauvres de la population mondiale.
CamerounpaludismeHAL · Unilimdocument de 98 observations
6,4 %Of 47 patients with type 1 diabetes, 3 (6.4%) had IA2 autoantibodies.
Cameroundiabète de type 1 · IA2 autoantibodiespublié 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument de 10 observations
19,5 %Based on body mass index, 19.5% of urban women in Cameroon were obese.
Camerounobésitépublié 2006BMC public healtheurope_pmcdocument de 6 observations
38,5 %38.5% of HIV-infected ART-naïve patients had insulin resistance.
Camerouninsulin resistancepublié 2017Lipids in health and diseaseeurope_pmcdocument de 7 observations
2,5 %D’ici 2027, le Ministère de la Santé Publique du Cameroun vise une réduction du taux de prévalence du paludisme chez les enfants de 6 à 59 mois à 2,5 %.
Camerounpaludismeobservé 2027HAL · Unilimdocument de 98 observations
17 patientsProximal muscle weakness was noted in all 17 Cameroonian Duchenne Muscular Dystrophy patients.
CamerounDuchenne Muscular Dystrophypublié 2020Molecular genetics & genomic medicineeurope_pmcdocument de 11 observations
56,7 yearsThe mean age of type 2 diabetes patients in the study was 56.7 years.
Cameroundiabète de type 2publié 2012Cardiovascular journal of Africaeurope_pmcdocument de 11 observations
8,1 %In the Monatélé Health District, 7 of the 78 surveyed communities had a prevalence of suspected cases of epilepsy exceeding 5.0%, with the highest value being 8.1% in Levem.
CamerounépilepsieHAL · Unilimdocument de 53 observations
11,1 %Over 5,504 person-years, 414 patients died (11.1%).
CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.